Elizaveta V Benevolenskaya

7PUBLICATIONS
15CO-AUTHORS
Metabolic medicineHaematological tumoursPredictive and prognostic markersMolecular targetsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 30, 2026
Obesity Disrupts H3K4me3-Mediated Lactate Accumulation and Efferocytosis in Hypoxic Macrophages.

Kentaro Takahashi, Julia Drolet, Jinghua Liu

|Jun 27, 2022
Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis.

Vaibhav Chand, Xiubei Liao, Grace Guzman

|Apr 27, 2022
Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer.

Daniel R Principe, Alexandre F Aissa, Sandeep Kumar

|Mar 13, 2021
Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer.

Alexandre F Aissa, Abul B M M K Islam, Majd M Ariss

|May 11, 2019
Sox17 is required for endothelial regeneration following inflammation-induced vascular injury.

Menglin Liu, Lianghui Zhang, Glenn Marsboom

|Jan 26, 2018
Honokiol is a FOXM1 antagonist.

Marianna Halasi, Ben Hitchinson, Binal N Shah

Pageof 2